MIG
MACK

Mariner Investment Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Mariner Investment Group’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,019
Closed -$340K – 140
2016
Q2 		$340K Hold
8,019
– – 0.11% 103
2016
Q1 		$528K Hold
8,019
– – 0.15% 119
2015
Q4 		$498K Sell
8,019
-4,067
-34% -$286K 0.11% 150
2015
Q3 		$809K Buy
12,086
+4,830
+67% +$394K 0.16% 133
2015
Q2 		$706K Buy
+7,256
New +$690K 0.18% 120

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Mariner Investment Group's MACK Position: Q3 2016 in Review

Mariner Investment Group sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2016, closing a stake of 8,019 shares — an estimated $340K sold.

Mariner Investment Group first reported a position in MACK in Q2 2015 and held it in 5 quarters. The position peaked at $809K in Q3 2015. 128 funds tracked by Wall St. Rank hold MACK as of Q3 2016.

  • Mariner Investment Group reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Mariner Investment Group sold 8,019 Merrimack Pharmaceuticals, Inc. shares in Q3 2016, an estimated $340K.
  • Mariner Investment Group first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2015 and held it in 5 quarters.
  • Mariner Investment Group's Merrimack Pharmaceuticals, Inc. position peaked at $809K in Q3 2015.
  • 128 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.